The Executive Director of AIPM confirmed that a third of manufacturers are still operating with the same product line.
Over 60% of foreign pharmaceutical companies operating in Russia are increasing their range of products available in the country, while a third of them are maintaining their existing product line. This was revealed by Larisa Matveeva, the Executive Director of the AIPM, during the Russian Pharmaceutical Semashko Forum.
«We conducted a survey among the members of the organization. When asked about the evolution of their product portfolio on the Russian market in the period from 2023 to 2024 and how it is expected to change in the next two years, 2025 and 2026, the responses were as follows: we maintain the same portfolio — 32% of companies, and we are expanding it — 61% of companies. In other words, more than 90% of companies are working on the same projects, and two-thirds are expanding their operations, » she stated.
Furthermore, the vast majority of businesses — 64% — stated that they are maintaining their operations in the Russian market without any modifications, while 31% are expanding their operations. Additionally, 35% of companies reported an increase in their development within the country, 8% reported no change, and 38% reported adapting and transforming.
There was a rumor that some international companies had withdrawn from the market. In fact, a few companies have exited the market, but the departure of two or three companies should not have a significant impact on the industry as a whole, as the remaining companies remain active. The statistics I have provided are very encouraging and demonstrate that the companies are still present and actively expanding, Matveeva emphasized.
Resource: TASS
Over 60% of foreign pharmaceutical companies operating in Russia are increasing their range of products available in the country, while a third of them are maintaining their existing product line. This was revealed by Larisa Matveeva, the Executive Director of the AIPM, during the Russian Pharmaceutical Semashko Forum.
«We conducted a survey among the members of the organization. When asked about the evolution of their product portfolio on the Russian market in the period from 2023 to 2024 and how it is expected to change in the next two years, 2025 and 2026, the responses were as follows: we maintain the same portfolio — 32% of companies, and we are expanding it — 61% of companies. In other words, more than 90% of companies are working on the same projects, and two-thirds are expanding their operations, » she stated.
Furthermore, the vast majority of businesses — 64% — stated that they are maintaining their operations in the Russian market without any modifications, while 31% are expanding their operations. Additionally, 35% of companies reported an increase in their development within the country, 8% reported no change, and 38% reported adapting and transforming.
There was a rumor that some international companies had withdrawn from the market. In fact, a few companies have exited the market, but the departure of two or three companies should not have a significant impact on the industry as a whole, as the remaining companies remain active. The statistics I have provided are very encouraging and demonstrate that the companies are still present and actively expanding, Matveeva emphasized.
Resource: TASS